Cell‐permeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis

Petri, Susanne, Kiaei, Mahmoud, Damiano, Maria, Hiller, Andrew, Wille, Elizabeth, Manfredi, Giovanni, Calingasan, Noel Y., Szeto, Hazel H., Beal, M. Flint·2006·Journal of Neurochemistry
DOI 10.1111/j.1471-4159.2006.04018.x

Cited by (166)

Items 101–166 of 166

  1. MnSOD deficiency has a differential effect on disease progression in two different ALS mutant mouse models
    Florian L. Müller, Yuhong Liu, Amanda Jernigan, David Borchelt, Arlan Richardson, Holly Van Remmen · 2008 · Muscle & Nerve
  2. Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms
    Sameera Khan, Nargis Bano, Shakir Ahamad, Urmilla John, Nawab John Dar, Shahnawaz Ali Bhat · 2024 · Aging and Disease
  3. Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology
    Ivana Matić, Daniela Strobbe, Michele Frison, Michelangelo Campanella · 2015 · Pharmacological Research
  4. SS-31 as a Mitochondrial Protectant in the Treatment of Tendinopathy
    Xueying Zhang, Edward Bowen, Meng Zhang, Hazel H. Szeto, Xiang‐Hua Deng, Scott Alan Rodeo · 2022 · Journal of Bone and Joint Surgery
  5. Mitochondria: Prospective Targets for Neuroprotection in Parkinson’s Disease
    Anuradha Yadav, Swati Agarwal, Shashi Kant Tiwari, Rajnish Kumar Chaturvedi · 2014 · Current Pharmaceutical Design
  6. Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration
    Khalid Bashir Dar, Aashiq Hussain Bhat, Shajrul Amin, Bilal Ahmad Reshi, Mohammad Afzal Zargar, Akbar Masood, Showkat Ahmad Ganie · 2019 · Cellular and Molecular Neurobiology
  7. The Mitochondria‐Targeted Peptide Therapeutic Elamipretide Improves Cardiac and Skeletal Muscle Function During Aging Without Detectable Changes in Tissue Epigenetic or Transcriptomic Age
    Wayne Mitchell, Gavin A. Pharaoh, Alexander Tyshkovskiy, Matthew Campbell, David Joseph Marcinek, Vadim N. Gladyshev · 2025 · Aging Cell
  8. Design of novel fluorescent mitochondria-targeted peptides with iron-selective sensing activity
    Vincenzo Abbate, Olivier Reelfs, Robert C. Hider, Charareh Pourzand · 2015 · Biochemical Journal
  9. Evaluation of the antioxidant peptide SS31 for treatment of burn-induced insulin resistance
    Alan J. Fischman · 2011 · International Journal of Molecular Medicine
  10. Neuroprotective Potential of Cell-Based Therapies in ALS: From Bench to Bedside
    Serhiy Forostyak, Eva Syková · 2017 · Frontiers in Neuroscience
  11. A method comparison in monitoring disease progression of G93A mouse model of ALS
    Chang Zhou, Cuiping Zhao, Chen Zhang, G. Y. Wu, Fu Xiong, Zhang Cheng · 2007 · Amyotrophic Lateral Sclerosis
  12. Mitochondria-targeted nanotherapeutics: A new frontier in neurodegenerative disease treatment
    Nishad Keethedeth, Rajesh Anantha Shenoi · 2024 · Mitochondrion
  13. Trends in Mitochondrial Therapeutics for Neurological Disease
    Ana Leitão-Rocha, Pedro Guedes-Dias, Brígida R. Pinho, Jorge M. A. Oliveira · 2015 · Current Medicinal Chemistry
  14. Protective effects of SS31 on t-BHP induced oxidative damage in 661W cells
    WEI MA, Xiaobo Zhu, Xiaoyan Ding, Tao Li, Yijun Hu, Xuting Hu, LIN YUAN, Lei Lei, Andina Hu, Yan Luo et al. · 2015 · Molecular Medicine Reports
  15. Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice
    Yue‐Ming Zhang, Ya‐Tao Wang, Ru‐Meng Wei, Xue‐Yan Li, Bao‐Ling Luo, Jing‐Ya Zhang, Kai‐Xuan Zhang, Shi‐Kun Fang, Xue‐Chun Liu, Gui‐Hai Chen · 2024 · Brain and Behavior
  16. Mitochondria-Targeted Antioxidant SS-31 is a Potential Novel Ophthalmic Medication for Neuroprotection in Glaucoma.
    Yu Pang, Chao Wang, Ling Yu · 2015 · Medical Hypothesis Discovery & Innovation in Ophthalmology
  17. SS31 Confers Cerebral Protection by Reversing Mitochondrial Dysfunction in Early Brain Injury Following Subarachnoid Hemorrhage, via the Nrf2- and PGC-1α-Dependent Pathways
    Jian Zhou, Ruiming Shen, Emmanuel Costantine Makale, Wangwang Zhong, Zhenggang Chen, Qiuhu Huang · 2022 · Neurochemical Research
  18. The Bcl-2 Homology-3 Domain (BH3)-Only Proteins, Bid, DP5/Hrk, and BNip3L, Are Upregulated in Reactive Astrocytes of End-Stage Mutant SOD1 Mouse Spinal Cord
    Duval, Nathan, Sumner, Whitney A., Andrianakos, Anna G., Gray, Josie J., Bouchard, Ron J., Wilkins, Heather M., Linseman, Daniel A. · 2018 · Frontiers in Cellular Neuroscience
  19. Hypochlorite modified albumins promote cell death in the tubule interstitium in rats via mitochondrial damage in obstructive nephropathy and the protective effects of antioxidant peptides
    Zongrui Liu, Si‐Qi Chen, Yao-Wei Zou, Xiao-Yu Wu, Hongying Li, Xiao-Qiao Wang, Yue Shi, Hongxin Niu · 2018 · Free Radical Research
  20. Protective down-regulated states in the human brain: A possible lesson from COVID-19
    Nicholas D. Schiff, Emery N. Brown · 2022 · Proceedings of the National Academy of Sciences
  21. Activating mitofusins interrupts mitochondrial degeneration and delays disease progression in SOD1 mutant amyotrophic lateral sclerosis
    Xiawei Dang, Lihong Zhang, Antonietta Franco, Gerald W. Dorn · 2022 · Human Molecular Genetics
  22. Nanozymes targeting mitochondrial repair in disease treatment
    Yuan Zhang, Shuxian Ma, Wenguang Chang, Wanpeng Yu, Lei Zhang · 2024 · Journal of Biotechnology
  23. Advances in pharmacotherapy for acute kidney injury
    Yali Xu, Ping Zou, Xiaojing Cao · 2022 · Expert Opinion on Pharmacotherapy
  24. SS31 Ameliorates age-related activation of NF-κB signaling in senile mice model, SAMP8
    Zhihua Hao, Yue Ming Huang, Meirong Wang, Tiantian Huo, Qian Jia, Rong-Fang Feng, Ping Fan, Jian-Hua Wang · 2016 · Oncotarget
  25. Targeted to neuronal organelles for CNS drug development
    Zheng Ying, Na Ye, Qilian Ma, Fan Chen, Ningning Li, Xuechu Zhen · 2023 · Advanced Drug Delivery Reviews
  26. Nanoparticle‐based therapeutic strategies for mitochondrial dysfunction in cardiovascular disease
    Isabella Suzuki, Huihua Xing, Joshua Giblin, Anisa Ashraf, Eun Ji Chung · 2024 · Journal of Biomedical Materials Research Part A
  27. Influence of metformin on mitochondrial subproteome in the brain of apoE knockout mice
    Maciej Suski, Rafał Olszanecki, Łukasz Chmura, Aneta Stachowicz, Józef Madej, Krzysztof Okoń, Dariusz Adamek, Ryszard Korbut · 2015 · European Journal of Pharmacology
  28. Mitochondrial Targeted Interventions for Aging
    Sophia Z. Liu, Ying Ann Chiao, Peter S. Rabinovitch, David Joseph Marcinek · 2023 · Cold Spring Harbor Perspectives in Medicine
  29. In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis
    Toluwase Hezekiah Fatoki, Stanley Chukwuejim, Chibuike C. Udenigwe, Rotimi Emmanuel Aluko · 2023 · International Journal of Molecular Sciences
  30. Proteomic analysis of cortical neuronal cultures treated with poly-arginine peptide-18 (R18) and exposed to glutamic acid excitotoxicity
    Gabriella MacDougall, Ryan S. Anderton, Frank Louis Mastaglia, Neville W. Knuckey, Bruno P. Meloni · 2019 · Molecular Brain
  31. Protective Effect of Mitochondrially Targeted Peptide Against Oxidant Injury of Cone Photoreceptors Through Preventing Necroptosis Pathway
    Yuan He, Yang Y. Xu, Zejun Chen, Beilei He, Zhuoya Quan, Ruixue Zhang, Yuan Ren · 2021 · Journal of Biomedical Nanotechnology
  32. [Retracted] Mitochondrial‐Targeted Antioxidant Peptide SS31 Prevents RPE Cell Death under Oxidative Stress
    Yuan He, Zejun Chen, Ruixue Zhang, Zhuoya Quan, Yang Y. Xu, Beilei He, Yuan Ren · 2022 · BioMed Research International · Retracted
  33. A 50 kdyne contusion spinal cord injury with or without the drug SS‐31 was not associated with major changes in muscle mass or gene expression 14 d after injury in young male mice
    Zachary Graham, Jennifer J. DeBerry, Christopher P. Cardozo, Marcas M. Bamman · 2021 · Physiological Reports
  34. The 2-Oxoglutarate Carrier Is S-Nitrosylated in the Spinal Cord of G93A Mutant hSOD1 Mice Resulting in Disruption of Mitochondrial Glutathione Transport
    Daniel A. Linseman, Aimee N. Winter, Heather Wilkins · 2022 · Biomedicines
  35. Immunotherapeutic Approaches in Prion Disease: progress, Challenges and Potential Directions
    Marcus W. Brazier, Alexandra I. Mot, Anthony Robert White, Steven John Collins · 2013 · Therapeutic Delivery
  36. Delivery of Biologically Active Molecules to Mitochondria
    Diana Guzman‐Villanueva, Volkmar Weissig · 2016 · Springer eBooks
  37. Targeting cellular batteries for the therapy of neurological diseases
    Arpita Arora, Tapan Behl, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Bijo Mathew, SIMONA GABRIELA BUNGAU · 2021 · Environmental Science and Pollution Research
  38. Exploiting endobiotic metabolic pathways to target xenobiotic antioxidants to mitochondria
    M.W. Anders · 2012 · Mitochondrion
  39. A chemogenomic approach is required for effective treatment of amyotrophic lateral sclerosis
    Georgios Pampalakis, Georgios Angelis, Eleni Zingkou, Kostas Vekrellis, Georgia Sotiropoulou · 2022 · Clinical and Translational Medicine
  40. Cardiac Aging
    Dao‐Fu Dai, Ying Ann Chiao, Robert J. Wessells, Rolf Bodmer, Hazel H. Szeto, Peter S. Rabinovitch · 2015 · Elsevier eBooks
  41. Cardiolipin and mitochondrial membrane integrity in neurodegeneration: insights from α-synuclein-driven Parkinson’s disease
    Eva Ruiz, Anna Wilkaniec, Josué Juárez, Agata Adamczyk · 2025 · Acta Neuropathologica Communications
  42. New Insights on Mitochondria-Targeted Neurological Drugs
    Silvia Lores‐Arnaiz · 2026 · Biology
  43. Multifunctional Radical Quenchers as Potential Therapeutic Agents for the Treatment of Mitochondrial Dysfunction
    Xun Ji, Omar M. Khdour, Sidney M. Hecht · 2019 · Future Medicinal Chemistry
  44. Preclinical testing of potential therapeutics for Amyotrophic Lateral Sclerosis
    Hannah Kaneb · 2012 · Spiral (Imperial College London)
  45. Potential Therapeutic Strategies for Neurodegenerative Diseases
    A. A. Farooqui · 2010 · Springer eBooks
  46. The potential of mitochondrially-targeted tetrapeptide in protecting against noise-induced hearing impairment
    Niranj A. Kumar, Azmi Marouf, Kumar N. Alagramam, Ruben Stepanyan · 2024 · Neuroreport
  47. Melatonin and Other Neuroprotective Agents Target Molecular Mechanisms of Disease in Amyotrophic Lateral Sclerosis
    Anastasios Fotinos, Yongjin Zhu, Lilly L. J. Mao, Nazem Atassi, Edward Zhou, Sarfraz Ahmad, Yingjun Guan, James D. Berry, Merit Cudkowicz, Xin Wang · 2016 · Springer eBooks
  48. Mitochondrial dysfunction in metabolic disorders
    Dia Advani, Sudhanshu Sharma, Rahul S. Tripathi, Rohan V. Gupta, Asmita Jaiswal, Rashmi K. Ambasta, Pravir Kumar · 2021 · Elsevier eBooks
  49. Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease
    María Calvo-Rodríguez, Elizabeth K. Kharitonova, Austin C. Snyder, Steven S. Hou, Maria Virtudes Sanchez-Mico, Sudeshna Das, Zhanyun Fan, Hamid Shirani, K. Peter R. Nilsson, Alberto Serrano‐Pozo et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  50. The mitochondrial-targeted peptide therapeutic elamipretide improves cardiac and skeletal muscle function during aging without detectable changes in tissue epigenetic or transcriptomic age
    Wayne Mitchell, Gavin A. Pharaoh, Alexander Tyshkovskiy, Matthew D. Campbell, David Joseph Marcinek, Vadim N. Gladyshev · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Redox state of aging skin: A double-edged sword in wound healing
    Qian Chen, Alex Sophabmixay, Thomas Albertson, Gabby Ghasb, Anna Terzian, Lloyd Yan, Lindon Howard Young, Robert Barsotti · 2024 · Advances in biogerontology
  52. On the Antioxidant Effect of SS-20 Tetrapeptide on Mitochondria and Cells
    Tatiana N. Goleva, V. O. Khvastunov, Anton G. Rogov · 2024 · Nanobiotechnology Reports
  53. Role of Mitochondrial Reactive Oxygen and Nitrogen Species in Respiratory Diseases
    Anantha K. Harijith, Prasad V.S. Kanteti, Panfeng Fu, Sainath R. Kotha, Narasimham L. Parinandi, Viswanathan Natarajan · 2014 · Respiratory medicine
  54. Chapter Six - Mitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
    Carlotta Giorgi, Saverio Marchi, Icm Simoes, Zhangpin Ren, Giampaolo Morciano, Mariasole Perrone, Paulina Patalas‐Krawczyk, Sabine Borchard, Paulina Jędrak, Karolina Pierzynowska et al. · 2018 · UCL Discovery (University College London)
  55. Potential Therapies for Mitochondrial Dysfunction
    Claire Henchcliffe, M. Flint Beal · 2011 · Springer eBooks
  56. The urokinase system of plasminogen activator plays a role in amyotrophic lateral sclerosis (ALS) pathogenesis
    M. Flint Beal · 2008 · Experimental Neurology
  57. Análise da influência da microglia mutante na sobrevida do neurônio motor no modelo in vitro da esclerose lateral amiotrófica utilizando camundongos transgênicos para SOD1 humana
    Tatiana Duobles · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  58. Antioxidants and Anti-Inflammatory Drugs in the Treatment of Motor Neuron Disease
    Mohammad Ali Esmaeili, Mahmoud Kiaei · 2014 · Springer eBooks
  59. Exercise Training as a Therapeutic Potential for Respiratory Muscle Weakness in Patients with Amyotrophic Lateral Sclerosis
    Bumsoo Ahn, Sang‐Hoon Suh, Il‐Young Paik · 2018 · Exercise Science
  60. Mitochondria and Neurodegenerative Diseases
    Ashu Johri, Abhishek Chandra · 2019 · Elsevier eBooks
  61. A chemogenomic approach seems indispensable for effective treatment of amyotrophic lateral sclerosis
    Georgios Pampalakis, Georgios Angelis, Pinelopi Kastana, Kostas Vekrellis, Georgia Sotiropoulou · 2021
  62. Therapeutic implications of targeting antioxidants to mitochondria
    Víctor M. Víctor, Teressa Vezza, Nadezda Apostolova, Milagros Rocha · 2021 · Elsevier eBooks
  63. Faculty Opinions recommendation of Mitochondrial ROS regulate oxidative damage and mitophagy but not age-related muscle fiber atrophy.
    Li Li Ji · 2019 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  64. Additional file 2 of Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease
    María Calvo-Rodríguez, Elizabeth K. Kharitonova, Austin C. Snyder, Steven S. Hou, Maria Virtudes Sanchez-Mico, Das, Sudeshna, Fan, Zhanyun, Hamid Shirani, K. Peter R. Nilsson, Alberto Serrano‐Pozo et al. · 2024 · Figshare
  65. Additional file 1 of Real-time imaging of mitochondrial redox reveals increased mitochondrial oxidative stress associated with amyloid β aggregates in vivo in a mouse model of Alzheimer’s disease
    María Calvo-Rodríguez, Elizabeth K. Kharitonova, Austin C. Snyder, Steven S. Hou, Maria Virtudes Sanchez-Mico, Das, Sudeshna, Fan, Zhanyun, Hamid Shirani, K. Peter R. Nilsson, Alberto Serrano‐Pozo et al. · 2024 · Figshare
  66. Importance du contrôle qualité des mitochondries dans les maladies neurodégénératives : analyse cellulaire et génétique dans des modèles drosophile de la maladie de Huntington et de la sclérose latérale amyotrophique
    Bilal Khalil · 2016 · theses.fr (ABES)